WDR5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.321200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.652800E-01
Normal-vs-Stage2
8.803200E-01
Normal-vs-Stage3
1.150000E-01
Normal-vs-Stage4
7.820000E-01
Stage1-vs-Stage2
3.159400E-01
Stage1-vs-Stage3
1.349970E-01
Stage1-vs-Stage4
3.899400E-01
Stage2-vs-Stage3
7.824100E-02
Stage2-vs-Stage4
9.135400E-01
Stage3-vs-Stage4
1.932440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.013800E-01
Normal-vs-AfricanAmerican
6.700000E-01
Normal-vs-Asian
8.095600E-01
Caucasian-vs-AfricanAmerican
6.264200E-01
Caucasian-vs-Asian
3.566400E-01
AfricanAmerican-vs-Asian
7.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.862600E-01
Normal-vs-Female
8.736800E-01
Male-vs-Female
5.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.572400E-01
Normal-vs-Age(41-60Yrs)
6.522400E-01
Normal-vs-Age(61-80Yrs)
9.370800E-01
Normal-vs-Age(81-100Yrs)
9.949800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.463400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.370800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.589400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.403800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.928600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.887600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.049400E-01
Normal-vs-Daily Drinker
9.037800E-01
Normal-vs-Weekly Drinker
6.594600E-01
Normal-vs-Occasional Drinker
3.444200E-01
Normal-vs-Social Drinker
5.167400E-01
Non Drinker-vs-Daily Drinker
1.826650E-01
Non Drinker-vs-Weekly Drinker
7.370000E-02
Non Drinker-vs-Occasional Drinker
1.268960E-01
Non Drinker-vs-Social Drinker
3.020000E-02
Daily Drinker-vs-Weekly Drinker
4.391800E-01
Daily Drinker-vs-Occasional Drinker
4.323600E-01
Daily Drinker-vs-Social Drinker
3.022000E-01
Weekly Drinker-vs-Occasional Drinker
8.931000E-01
Weekly Drinker-vs-Social Drinker
9.271600E-01
Occasional Drinker-vs-Social Drinker
9.407000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.774600E-01
Normal-vs-Grade 2
9.321800E-01
Normal-vs-Grade 3
9.755200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.841570E-01
Grade 1-vs-Grade 3
3.906400E-01
Grade 1-vs-Grade 4
8.774600E-01
Grade 2-vs-Grade 3
2.529800E-01
Grade 2-vs-Grade 4
9.321800E-01
Grade 3-vs-Grade 4
9.755200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.578800E-01
Normal-vs-NonDiabetic
8.010600E-01
Diabetic-vs-NonDiabetic
2.756400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.499800E-01
Normal-vs-NoPancreatitis
9.129400E-01
Pancreatitis-vs-NoPancreatitis
9.264000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.332000E-01
Normal-vs-N1
8.702400E-01
N0-vs-N1
9.850200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.393200E-01
Normal-vs-TP53-NonMutant
3.130600E-01
TP53-Mutant-vs-TP53-NonMutant
3.312600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
